PIK3CA and neoplasm: Many other clinical and histopathological factors have been related to pCR [33], and the predictive role of biomarkers, such as the 21-gene assay [34], PIK3CA mutation [35], Ki-67 index [36], and tumor-infiltrating lymphocytes [37], is being evaluated.